Terms ending in 2035
Every in-force patent on Cathay Biotech Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,538,481 | Method for Purifying 1,5-Pentanediamine and 1,5-Pentanediamine In force · High confidence | Cathay Biotech Inc. | In force | High confidence | |
| US 10,584,149 | Expression of Klebsiella Oxytoca Polypeptides Involved in Lysine Decarboxylation, and Methods and Applications Thereof In force · High confidence | Cathay Biotech Inc. | In force | High confidence | |
| US 11,261,217 | Expression of Klebsiella Oxytoca Polypeptides Involved in Lysine Decarboxylation, and Methods and Applications Thereof In force · High confidence | Cathay Biotech Inc. | In force | High confidence | |
| US 10,619,148 | Immobilized Cell and Preparation Method Thereof In force · High confidence | Cathay Biotech Inc. | In force | High confidence | |
| US 10,501,503 | Modified Membrane Permeability In force · High confidence | Cathay Biotech Inc. | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.